October 24, 2011 — BioCrossroads’ Indiana Seed Fund has announced its twelfth investment, committing $300,000 to medical device start-up Zorion Medical. Zorion is developing a breakthrough device combining novel biomaterials with known drug and drug delivery technology in a unique design to treat cardiovascular disease.
